Notify Me
Cipla Ltd (Generics)

Ceftaz 1gm Injection 1's

MRP ₹166.85 (Inclusive of all taxes)
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About CEFTAZ 1GM INJECTION

    CEFTAZ 1GM INJECTION contains Cefuroxime which belongs to the group of medicines called Antibiotics. It is used to manage bacterial infections such as lower respiratory tract infections, meningitis, septicemia, abdominal infections, urinary tract infections, skin and soft tissue infections, ear, nose and throat infections, obstetric and gynecological infections, bone, joint infections and gonorrhea. CEFTAZ 1GM INJECTION is also used to manage infections, before and after surgery.

    Tell your doctor before receiving CEFTAZ 1GM INJECTION if you have or had a history of kidney or liver diseases, fungal diseases or diarrhoea. If you are pregnant or breastfeeding, inform your doctor before receiving CEFTAZ 1GM INJECTION.

    Inform your doctor if you are allergic (hypersensitive) to cephalosporins, penicillin or any antibiotics before receiving the medicine.

    Your doctor will administer the right dose depends on your child’s age, body weight and disease condition. CEFTAZ 1GM INJECTION should be used with caution in elderly patients, consult your doctor before receiving the medicine.

    The most common side effect of receiving this medicine is pain at the injection site, swelling and redness. Consult your doctor immediately if any of the above symptoms worsen.

    Uses Of CEFTAZ 1GM INJECTION

    Used to manage:

    • respiratory tract infections
    • urinary tract infections
    • ear, nose, throat infections
    • soft tissue infections

    How CEFTAZ 1GM INJECTION Works

    CEFTAZ 1GM INJECTION contains cefuroxime which is a second-generation cephalosporin that interferes with the synthesis of the bacterial cell wall by binding to specific binding proteins located inside the bacterial cell wall. This leads to breaking down the cell wall of the bacteria and reducing its stability, thus causing cell damage, and eventually causing bacterial elimination.  

    How to use CEFTAZ 1GM INJECTION

    CEFTAZ 1GM INJECTION will be given to you only by a doctor or nurse by intramuscular (into a muscle) or intravenous (into the vein) injection. Your doctor will administer the correct dose for you depending upon your age, body weight and disease condition.

    Side Effects Of CEFTAZ 1GM INJECTION

    Common

    • pain (injection site), swelling and redness along a vein
    • increase in liver enzyme
    • changes in white blood cells (neutropenia or eosinophilia)
    • low levels of red blood cells (anemia)
    • high temperature
    • sore throat

    Uncommon

    • skin rashes, urticaria (itchy red wheals), pruritus (bumpy rash)
    • gastrointestinal disturbances, diarrhoea, nausea
    • increase in bilirubin (a substance produced by the liver)
    • positive coomb’s test

    Rare

    Stop receiving CEFTAZ 1GM INJECTION and consult your doctor immediately if you experience any of the following side effects

    • severe allergic reaction (raised and itchy rash, swelling on face, mouth causing difficulty to breath)
    • skin rash with blisters and peeling of skin (signs of Steven-Johnson’s syndrome/ toxic epidermal necrolysis)
    • skin rash with blisters looking like a small dark spot surrounded by a paler area, with a dark ring around the edge
    • fungal infections
    • severe diarrhoea (Pseudomembranous colitis), causing severe diarrhoea, usually with blood and mucus, stomach pain, and fever

    Warning & Precautions

    Pregnancy

    The safety of CEFTAZ 1GM INJECTION during pregnancy has not been clearly established. The use of this medicine in pregnant women requires that the potential benefit from the drug be weighed against the possible risk to the mother and fetus. Consult your doctor before receiving.

    Breastfeeding

    CEFTAZ 1GM INJECTION should be used with caution as it may pass into the breast milk. Consult your doctor before receiving.

    Driving and Using Machines

    Do not drive or operate heavy machines if you feel dizziness after receiving CEFTAZ 1GM INJECTION.

    Kidney

    CEFTAZ 1GM INJECTION should be used with caution in patients with a history of kidney problems. Consult your doctor before receiving the medicine.

    Liver

    CEFTAZ 1GM INJECTION should be used with caution in patients with a history of liver problems. Consult your doctor before receiving CEFTAZ 1GM INJECTION.

    Allergy

    Do not receive CEFTAZ 1GM INJECTION if you are allergic (hypersensitive) to Cefuroxime, cephalosporin, penicillin, monobactams, carbapenems or to any other ingredients of this medicine.

    Others

    CEFTAZ 1GM INJECTION should be avoided if you have severe persistent diarrhoea along with sickness.

    Before receiving CEFTAZ 1GM INJECTION, inform your doctor if you:

    • have allergic skin reaction such as rashes
    • have gastrointestinal disorder (diarrhoea)
    • fungal infection

    Use in pediatrics:

    Your doctor will administer the right dose depends on your child’s age, body weight and severity of the infection. Consult your doctor before receiving CEFTAZ 1GM INJECTION.

    Use in geriatrics:

    CEFTAZ 1GM INJECTION should be used with caution in elderly patients suffering kidney problems. Consult your doctor before receiving.

    Interactions

    A. Drug-Drug interactions:

    Before receiving CEFTAZ 1GM INJECTION, inform your doctor if you are receiving any of the following medicine:

    • medicine to manage bacterial infections such as aminoglycoside-type antibiotics (Ex. gentamycin)
    • medicine used to manage increase high blood pressure (Ex. furosemide)
    • medicine used to manage gout (Ex. probenecid)
    • medicine used to manage blood clots such as oral anticoagulants (Ex. warfarin)
    • medicines used for contraception (Ex. ethinyl estradiol)

    Overdosage:

    It is unlikely to receive overdose since it will be administered by the doctor or nurse. If you experience any unusual side effects, consult your doctor immediately.

    Synopsis

    Drug :  

    Cefuroxime

    Pharmacological Category :  

    Cephalosporin Antibiotics

    Therapeutic Indication :  

    Manages Bacterial infections

    Dosage Forms :  

    Tablet, Injection, Capsule, Syrup, Dry Suspension, Drops, Dispersible tablet

    More Information

    • Keep out of reach of children
    • Store at room temperature

    FAQs About CEFTAZ 1GM INJECTION

    What is CEFTAZ 1GM INJECTION used for?

    It is used to manage bacterial infections such as lower respiratory tract infections, meningitis, septicemia, abdominal infections, urinary tract infections, skin and soft tissue infections, ear, nose and throat infections, obstetric and gynecological infections, bone, joint infections and gonorrhea. CEFTAZ 1GM INJECTION is also used to manage infections, before and after surgery.

    Can I take oral contraceptive pills while receiving CEFTAZ 1GM INJECTION?

    No. CEFTAZ 1GM INJECTION may interact with birth control pills and lowers its efficiency. So, you should tell your doctor if you are using any birth control pills as it may lead to unwanted pregnancies.

    Can CEFTAZ 1GM INJECTION be given to breastfeeding mothers?

    CEFTAZ 1GM INJECTION should be used with caution as it may pass into the breast milk. Consult your doctor before receiving. It should only be given if the expected benefits outweigh any potential risk to the baby.

    Can CEFTAZ 1GM INJECTION cause diarrhoea?

    Yes, CEFTAZ 1GM INJECTION may cause serious diarrhea during or after use. Usually, discontinuation of medicine can subside diarrhea. However, if diarrhea persists or if there is blood in the stool then immediately consult your doctor.

    In what condition CEFTAZ 1GM INJECTION should be avoided?

    Before receiving CEFTAZ 1GM INJECTION tell your doctor if you have a history of serious anaphylactic reaction to cefuroxime or any other cephalosporin antibiotics.

    References

    1. KD Tripathi. Beta-Lactam Antibiotics. Essentials of Medical Pharmacology. Seventh Edition,2013. Page - 727.

    2. Gold B, Rodriguez WJ. Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions and therapeutic indications. National Library of Medicine. PubMed Central (PMC). [Accessed on 7th September 2022] https://pubmed.ncbi.nlm.nih.gov/6344037/

    3. GlaxoSmithKline Manufacturing S.P.A. [Revised in July 2014] [Accessed on 7th September 2022] https://gskpro.com/content/dam/global/hcpportal/en_GE/PI/Zinacev-PIL-GDSv31-2016-02-05.pdf

    4. Hawke’s Bay Hospital Pharmacy Revised in August 2008] [Accessed on 7th September 2022] https://gskpro.com/content/dam/global/hcpportal/en_GE/PI/Zinacev-PIL-GDSv31-2016-02-05.pdf

    5. Acs Dobfar S.P.A. The Electronic Medicines Compendium (emc). [Revised in May 2022] [Accessed on 7th September 2022] https://www.medicines.org.uk/emc/files/pil.149.pdf

    6. Hikma Pharmaceuticals USA Inc. [Revised in April 2020] [Accessed on 7th September 2022] https://hawkesbay.health.nz/assets/Patient-Medication-Information/Cefuroxime-PIL.pdf

    7. Villerton Invest SA. The Electronic Medicines Compendium (emc). [Revised in May 2021] [Accessed on 7th September 2022] https://www.medicines.org.uk/emc/files/pil.8747.pdf

    8. Hikma Pharmaceuticals USA Inc. [Revised in May 2021] [Accessed on 7th September 2022] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=703cc338-c0b6-4a02-b8db-c27aeff181df

    9. Fresenius Kabi Canada Ltd. [Revised in April 2020] [Accessed on 7th September 2022] https://www.fresenius-kabi.com/fr-ca/documents/Cefuroxime-PM-ENG-v6.0-052820.pdf

    10. GlaxoSmithKline South Africa (Pty) Ltd. [Revised in September 2000] [Accessed on 7th September 2022] https://www.fresenius-kabi.com/fr-ca/documents/Cefuroxime-PM-ENG-v6.0-052820.pdf

    11. Facta Farmaceutici S.P.A. [Revised in September 2018] [Accessed on 7th September 2022] https://www.hpra.ie/img/uploaded/swedocuments/2204203.PA1226_009_002.af47d81e-3068-479b-9c91-8a209488572d.000001Cefuroxime%20PIL.180710.pdf

    12. Acs Dobfar Spa. [Revised in May 2021] [Accessed on 7th September 2022] https://www.medicines.org.uk/emc/files/pil.8747.pdf

    13. Biopharma S.R.L. [Revised in August 2019] [Accessed on 7th September 2022]  https://www.hpra.ie/img/uploaded/swedocuments/16a140d0-b6c7-4bce-94ec-01f2c5a8858c.pdf                                           

    14. Ciplamed. [Revised in July 2016] [Accessed on 7th September 2022] https://www.ciplamed.com/content/novacef-injection

    15. GlaxoSmithKline Pvt. Ltd. [Revised in August 2001] [Accessed on 7th September 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/50643s11lbl.pdf

    Useful Diagnostic Tests

    • Complete Blood Count

    Author Details

    Written By Dr. Janet.C - Pharm.D
    Reviewed For Accuracy By Dr. Salem Gill - MBBS
    Last updated on 05 Oct 2022 | 11:53 AM(IST)
    Lab updated